Mandarin Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023

/PRNewswire/ Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development,.

United kingdomHong kongUnited statesSouth koreaMacau special administrative regionMacau generalRogers yongqing luoHainan boaoAdministration bureauGilead sciences incImmunomedics incVenatorx pharmaceuticalsPfizer incBusiness developmentKorea ministry of foodFudan university

Everest Medicines Announces China NMPA s Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients

Everest Medicines Announces China NMPA s Approval of Nefecon® for the Treatment of Primary IgA Nephropathy in Adult Patients
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth koreaHong kongZhang hongXie jingyuanRogers yongqing luoChina national medical products administrationDrug administrationWhile the companyShanghai jiao tong university school of medicineEuropean unionAmerican society of nephrologyEuropean medicines agencyPhysician of the department nephrologyUniversity first hospital

Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon® Chinese Patient Data and to Hold Conference Calls

/PRNewswire/ Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and.

United kingdomUnited statesHong kongAmerican society of nephrologyD pennsylvania convention centerAmerican societyKidney weekBreaking poster presentation detailsLate breaking postersPennsylvania convention centerCall detailsEnglish sessionRegistration linkMandarin sessionEverest medicines

Everest Medicines to Announce First Half 2023 Financial Results on August 24, 2023

/PRNewswire/ Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and.

United statesUnited kingdomHong kongBeijing timeEnglish sessionRegistration linkMandarin sessionEverest medicines

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2022

/PRNewswire/ Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing, manufacturing and.

South koreaUnited statesHong kongRepublic ofUnited kingdomXerava eravacyclineRogers yongqing luoEuropean medicines agencyEuropean commissionBusiness development updatesVenatorx pharmaceuticalsBoao lecheng international medical tourism pilot zonePfizer incDrug administrationImmunomedics incNew drug application